The results of this study suggest that myeloid-specific GSK3α (and GSK3αβ) deficiency reduces atherosclerosis and inflammation in atherosclerotic lesions and reduces vasa vasorum density at the aortic sinus in Ldlr−/− mice. This evidence concerns the gene GSK3A and atherosclerosis.